Zacks.com on MSN1 天
Axsome Gets FDA Nod for New Migraine Drug Symbravo, Stock Rises
Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert ...
The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...
Axsome gets FDA approval for Symbravo for migraine
Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or ...